Organon (OGN) Current Assets (2020 - 2026)
Organon (OGN) posted quarterly Current Assets of $5.1 billion for Q2 2026, up 10.68% year-over-year from $4.6 billion in Q2 2025, and up 3.63% on a QoQ basis from $4.9 billion in Q1 2026.
Organon (OGN) Current Assets (2020 - 2026) Analysis & Trends
Organon has reported Current Assets for 7 years, with the latest figure at $5.1 billion in Q2 2026.
- Current Assets for Q2 2026 came in at $5.1 billion, up 10.68% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.1 billion (up 10.68% YoY), and the FY2025 annual result was $4.4 billion, changed 0.09% from the prior year.
- Current Assets improved to $5.1 billion in Q2 2026, from $4.9 billion in the prior quarter.
- Over five years, Current Assets peaked at $5.1 billion in Q2 2026 and troughed at $3.6 billion in Q3 2022.
- A 5-year average of $4.3 billion and a median of $4.4 billion in 2024 frame the typical range for Current Assets.
- The largest YoY upside for Current Assets was 24.92% in 2022 against a maximum downside of 17.02% in 2022.
- A 5-year view of Current Assets shows it stood at $3.9 billion in 2022, then grew by 14.68% to $4.5 billion in 2023, then slipped by 3.55% to $4.3 billion in 2024, then climbed by 0.09% to $4.4 billion in 2025, then gained by 17.44% to $5.1 billion in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $5.1 billion in Q2 2026, $4.9 billion in Q1 2026, and $4.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 23.56 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 5.11 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.11 Bn |
| Mar 31, 2026 | 4.93 Bn |
| Dec 31, 2025 | 4.35 Bn |
| Sep 30, 2025 | 4.70 Bn |
| Jun 30, 2025 | 4.62 Bn |
| Mar 31, 2025 | 4.37 Bn |
| Dec 31, 2024 | 4.35 Bn |
| Sep 30, 2024 | 4.76 Bn |
| Jun 30, 2024 | 4.51 Bn |
| Mar 31, 2024 | 4.20 Bn |
| Dec 31, 2023 | 4.51 Bn |
| Sep 30, 2023 | 4.05 Bn |
| Jun 30, 2023 | 3.96 Bn |
| Mar 31, 2023 | 3.78 Bn |
| Dec 31, 2022 | 3.93 Bn |
| Sep 30, 2022 | 3.59 Bn |
| Jun 30, 2022 | 3.77 Bn |
| Mar 31, 2022 | 3.72 Bn |
| Dec 31, 2021 | 3.76 Bn |
| Sep 30, 2021 | 4.33 Bn |